Article metrics

Original article
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

 

Online download statistics by month:

Online download statistics by month: March 2015 to April 2021

AbstractFullPdf
Mar 2015686260211
Apr 201523116984
May 2015907334
Jun 20159111130
Jul 2015636032
Aug 2015624618
Sep 2015756023
Oct 2015283212
Nov 2015846117
Dec 20151076117139
Jan 201670988131
Feb 20163396755
Mar 20162654349
Apr 20162055847
May 20161464131
Jun 20161186252
Jul 20161226038
Aug 20161255629
Sep 20161607721
Oct 20161304627
Nov 20161757834
Dec 20161496521
Jan 20171485523
Feb 2017372814
Mar 201776218
Apr 201736821
May 201747519
Jun 201714485
Jul 2017706916
Aug 201760587
Sep 2017614813
Oct 2017887619
Nov 2017494713
Dec 201774708
Jan 201849453
Feb 2018433416
Mar 201859453
Apr 201863618
May 2018716610
Jun 201851497
Jul 201842427
Aug 2018636310
Sep 201876727
Oct 20181111099
Nov 201877738
Dec 201811310610
Jan 201991799
Feb 201981688
Mar 2019724814
Apr 2019363010
May 2019784214
Jun 2019373118
Jul 2019674520
Aug 2019352810
Sep 2019493219
Oct 201958347
Nov 2019322612
Dec 2019534412
Jan 202039358
Feb 2020823610
Mar 202077354
Apr 202057397
May 2020503415
Jun 2020361811
Jul 2020473414
Aug 2020301810
Sep 2020574723
Oct 202062377
Nov 2020321813
Dec 2020734938
Jan 2021653718
Feb 2021393023
Mar 2021523412
Apr 2021402619
Total808942331794